| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/14/2006 | WO2006132442A1 Vitamin d-like compound |
| 12/14/2006 | WO2006132321A1 Agent for preventing, ameliorating and treating phosphorus-induced disorder, oral preparation for adsorbing phosphate ion in food, drink or drug and method of producing the same |
| 12/14/2006 | WO2006132295A1 Regulator of aldosterone receptor |
| 12/14/2006 | WO2006132205A1 Radical scavenger and active oxygen eliminating agent |
| 12/14/2006 | WO2006132091A1 Novel triglyceride reducing agent |
| 12/14/2006 | WO2006130949A1 Anti amyloid-related disease molecules and their uses |
| 12/14/2006 | WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal |
| 12/14/2006 | US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis |
| 12/14/2006 | US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 12/14/2006 | US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/14/2006 | US20060281152 Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 12/14/2006 | US20060281095 44 human secreted proteins |
| 12/14/2006 | US20060280719 An addition polymer from an unsaturated monomer containing a phosphonate group and a phosphinate group separated from eachother by an optionally fluorinated methylene group; treatment of hyperphosphotemia, chronic renal failure, hyperparathyroidism, uremic bone disease, or osteoporosis |
| 12/14/2006 | CA2610956A1 Improved treatment for anemia using a hif-alpha stabilising agent |
| 12/13/2006 | EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3 |
| 12/13/2006 | EP1731516A2 The 9,11-cycloendoperoxide prodrugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 12/13/2006 | EP1731183A1 Solid pharmaceutical preparation for dialysis |
| 12/13/2006 | EP1731175A1 Hemostatic polymer useful for rapid blood coagulation and hemostatis |
| 12/13/2006 | EP1731168A1 Antibody drug |
| 12/13/2006 | EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 12/13/2006 | EP1731131A1 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
| 12/13/2006 | EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists |
| 12/13/2006 | EP1372737B8 Preparation for the prophylaxis of restenosis |
| 12/13/2006 | EP1261712B1 Proteins named fctrx and nucleic acids encoding same |
| 12/13/2006 | EP1171156B1 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin |
| 12/13/2006 | EP1124961B1 Thrombopoietic compounds |
| 12/13/2006 | EP1123392B1 Prv-1 gene and the use thereof |
| 12/13/2006 | EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 12/13/2006 | CN1878529A Combined cosmetic or therapeutic preparation |
| 12/13/2006 | CN1878464A Therapeutic delivery of carbon monoxide |
| 12/13/2006 | CN1876683A Human antibodies that bind human TNFalpha |
| 12/13/2006 | CN1876146A A Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 12/13/2006 | CN1876131A Medicine for treating nasal bleeding, toothache and stomatocace and preparation method thereof |
| 12/13/2006 | CN1876128A A medicine for treating metrorrhagia and preparation process thereof |
| 12/13/2006 | CN1876125A Medicine for treating cardiovascular and cerebrovascular disease and preparation method thereof |
| 12/13/2006 | CN1876067A A medicine for treating vaginal bleeding caused by drug induced abortion and method for preparing the same |
| 12/13/2006 | CN1876033A Compound Chinese preparation with gingko, its preparation method and use |
| 12/13/2006 | CN1876019A An injection containing phenylpropanolid glycosides, its preparation method and use |
| 12/13/2006 | CN1876009A Hemostatic notoginseng chewing tablet and preparation method thereof |
| 12/13/2006 | CN1876007A Asiabell preparation and preparation method thereof |
| 12/13/2006 | CN1875981A Injection emulsion containing breviscapinum and preparation method thereof |
| 12/13/2006 | CN1875972A Preparation of ligustrazine and ligustrazine salt drop pills utilizing nano technology |
| 12/13/2006 | CN1875926A Injectable composition of clopidogrel and its salt and preparation method thereof |
| 12/13/2006 | CN1289526C Stem cell factor |
| 12/13/2006 | CN1289499C Pirazino (aza) indole derivatives |
| 12/13/2006 | CN1289466C Pharmaceutical compounds |
| 12/13/2006 | CN1289141C Thrombogenesis inhibiting medicine |
| 12/13/2006 | CN1289140C Use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 12/13/2006 | CN1289128C A pharmaceutical composition for treating headache disease, preparation process and uses thereof |
| 12/12/2006 | US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 12/12/2006 | US7148247 Substituted benzoxazoles as estrogenic agents |
| 12/12/2006 | US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 12/12/2006 | US7148233 Treatment of cardiovascular and related pathologies |
| 12/12/2006 | CA2242618C Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons |
| 12/12/2006 | CA2098176C Angiotensin ii receptor blocking compositions |
| 12/07/2006 | WO2006130065A1 Peritoneal dialysis fluid |
| 12/07/2006 | WO2006129849A1 Anti-cd14 antibody-fused protein |
| 12/07/2006 | WO2006129785A1 Concomitant pharmaceutical agents and use thereof |
| 12/07/2006 | WO2006129784A1 INTERFERON-α REGULATOR |
| 12/07/2006 | WO2006129524A1 Carbonyl compound remover |
| 12/07/2006 | WO2006129468A1 Process for preparation of granular oral composition using oligosaccharide solution |
| 12/07/2006 | WO2006128885A2 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 12/07/2006 | WO2006086822A9 A molecule and chimeric molecules thereof |
| 12/07/2006 | US20060277614 Mammal prolactin variants |
| 12/07/2006 | US20060276634 PEG-conjugated erythropoietin |
| 12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 12/07/2006 | US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38 |
| 12/07/2006 | US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 12/07/2006 | US20060276470 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy |
| 12/07/2006 | US20060276455 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia |
| 12/07/2006 | US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability |
| 12/07/2006 | US20060276432 Lipid-regulating agent and use thereof |
| 12/07/2006 | US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/07/2006 | US20060276398 Combined use of factor VII polypeptides and factor VIII polypeptides |
| 12/07/2006 | US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein |
| 12/07/2006 | US20060276384 Peptides and medicinal compositions containing the same |
| 12/07/2006 | US20060276377 Factor VII or VIIa Polypeptide Variants |
| 12/07/2006 | US20060275348 Method for preventing or treating thrombosis |
| 12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
| 12/07/2006 | US20060275251 Polymer complexes of glucuronoglucanes |
| 12/07/2006 | DE102005025728A1 Polymorphe von Polymorphs of 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester |
| 12/07/2006 | CA2610413A1 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 12/07/2006 | CA2609262A1 Anti-cd14 antibody fusion protein |
| 12/06/2006 | EP1728794A1 Maleate addition salt of hydropyridine derivatives |
| 12/06/2006 | EP1728514A1 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 12/06/2006 | EP1728504A1 Emulsion stabilizer |
| 12/06/2006 | EP1727553A2 Agent for substitution of blood plasma and a method of its production |
| 12/06/2006 | EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof |
| 12/06/2006 | EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof |
| 12/06/2006 | EP1218381B1 AMINO SUBSTITUTED PYRAZOLO¬1,5-a|-1,5-PYRIMIDINES AND PYRAZOLO¬1,5-a|-1,3,5-TRIAZINES |
| 12/06/2006 | EP0983346B1 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 12/06/2006 | CN1873018A Target gene CK1 alpha of new medication |
| 12/06/2006 | CN1872881A Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods |
| 12/06/2006 | CN1872879A Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage |
| 12/06/2006 | CN1872337A Nasal cavity taking preparation of hirudin, and application |
| 12/06/2006 | CN1872302A Compound Chinese herbal medicine of fossil, and preparation method |
| 12/06/2006 | CN1872285A Drop pills of Chinese traditional medicine, and preparation method |
| 12/06/2006 | CN1872261A Drop pills of fine powder of dragons blood, and preparation method |